This effect was abrogated by transfection with either dominant negative MEK (a positive control) or our dnDAP12, demonstrating the important role of DAP12 in the activation of PMNs in RA inflammation (Fig. 5A). The gene discussed is MAP2K7; the disease is rheumatoid arthritis.